Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Verona Pharma LSE:VRP London Ordinary Share GB00BYW2KH80 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  -1.50p -2.10% 70.00p 11,138 09:43:29
Bid Price Offer Price High Price Low Price Open Price
65.00p 75.00p 71.00p 70.00p 71.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -25.20 -23.40 73.6

Verona Pharma (VRP) Latest News

More Verona Pharma News
Verona Pharma Takeover Rumours

Verona Pharma (VRP) Share Charts

1 Year Verona Pharma Chart

1 Year Verona Pharma Chart

1 Month Verona Pharma Chart

1 Month Verona Pharma Chart

Intraday Verona Pharma Chart

Intraday Verona Pharma Chart

Verona Pharma (VRP) Discussions and Chat

Verona Pharma Forums and Chat

Date Time Title Posts
21/1/201921:30Verona Pharma: Developing first in class drugs for respiratory diseases1,030
30/10/201808:41Still time to look at Verona Pharma (VRP)-
01/8/201809:42Verona Pharma (VRP) One to Watch -
16/2/201517:30Verona Pharma with Charts & News11,549
24/11/201112:54verona pharma173

Add a New Thread

Verona Pharma (VRP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
13:46:2565.501,000655.00O
13:41:1265.005,5203,588.00O
12:34:2968.22980668.56O
11:30:2771.0013897.98O
09:43:1168.203,5002,387.00O
View all Verona Pharma trades in real-time

Verona Pharma (VRP) Top Chat Posts

DateSubject
22/1/2019
08:20
Verona Pharma Daily Update: Verona Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker VRP. The last closing price for Verona Pharma was 71.50p.
Verona Pharma has a 4 week average price of 62p and a 12 week average price of 62p.
The 1 year high share price is 197.50p while the 1 year low share price is currently 62p.
There are currently 105,075,513 shares in issue and the average daily traded volume is 111,369 shares. The market capitalisation of Verona Pharma is £73,552,859.10.
09/1/2019
13:11
tomboyb: https://uk.advfn.com/stock-market/london/verona-pharma-VRP/share-news/Verona-Pharma-plc-Verona-Pharma-Receives-Who-Appro/79020332 I wonder if saffy is buying a few -
20/2/2018
19:43
combo83: The risk/reward here currently looks very favourable. Well funded, important newsflow within 1-2 months, consistent director buying, and different brokers with price targets at multiples of the current share price. GLA, could be a very interesting year. PS - timboo, perhaps time for an update of the header? :)
09/11/2017
12:04
haff1: Its a shame the share price doesnt reflect this..
23/6/2017
07:31
kwizza: Is this a new low for the share price
23/2/2017
11:22
shakin not stirred: I am waiting to see if Nasdaq listing makes a difference but need to get to £2 new money to break even. Will bale out when that is reached. Unless anything materially changes as to indicating a good news flow. At the moment it is a Jam tomorrow as have been the last few years for me and longer for others. None of us have invested in companys for F.A. but that is the current return at this moment in time. That is the current reality of the share price.
22/2/2017
07:46
vasilis: Phase 2a COPD trial official start as first patient dosed with expected top-line results in Q4 - http://uk.advfn.com/stock-market/london/verona-pharma-VRP/share-news/Verona-Pharma-PLC-First-COPD-patient-dosed-with-RP/73919813
15/2/2017
08:49
timbo003: The recent share price movement is a bit disappointing, but similar to that of Motif Bio immediately before it had its Nasdaq listing. With US listings for UK listed AIM companies, be careful of what you wish for!
25/1/2017
16:50
meijiman: The share price has not been too clever of late.......
20/1/2017
22:53
shakin not stirred: The belief is that the minimum share price on the nasdaq is $2 so that will happen and in my mind we will be fully subscribed and job don e with enough money to take it to commercialisation and GSK or alternatively large paharma like Bayer to buy a huge lump of shares, followed by a partnership deal. 9p equivalent old money this year and 20p eventual. All very good news.
23/11/2016
10:27
timbo003: I hope the US listing goes somewhat better than it did for Motif Bio (MTFB), which was a disaster as far as the share price was concerned
Verona Pharma share price data is direct from the London Stock Exchange
Your Recent History
LSE
VRP
Verona Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190122 18:35:30